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Open access under CC BY license.Recent years have revealed a high degree of structural
organisation in the way in which cell-surface receptors
and their associated signalling complexes interact at a
molecular level. Fluorescence-based techniques have
been at the forefront of methodologies used to investi-
gate this organisation and dissect the pharmacology of
drug–receptor interactions at the single-cell level. One
such technique, fluorescence correlation spectroscopy
(FCS), in conjunction with a fluorescent ligand or re-
ceptor, is capable of providing quantitative information
about the number of receptors and their mobilities
within small areas of the cell membrane that approach
the size of some signalling domains. This article
describes the use of FCS to perform subcellular quanti-
tative pharmacology, with particular reference to G-
protein-coupled receptors (GPCRs). In conjunction with
other forms of fluctuation analysis, such as two-colour
cross-correlation FCS andmolecular brightness analysis,
FCS provides the first opportunity to investigate the
domain-specific nature of GPCR pharmacology.
The need for single-cell pharmacology
The quantitative characterization of the interaction of a
ligand with its receptor in terms of affinity and efficacy has
been a mainstay of pharmacology since the concept of
receptors was first introduced. Such parameters were
derived initially from functional responses in isolated tis-
sue samples and are now obtained routinely from popu-
lations of thousands of cells to give valuable information
about ligand affinity, efficacy and binding capacity at a
macroscopic level. The calculation of these ligand proper-
ties requires an accurate knowledge of both the free and
bound concentrations of the drugs used. Mounting evi-
dence suggests that membrane receptors and their associ-
ated signalling molecules exist in a highly ordered
membrane environment [1–4]. This is particularly true
of G-protein-coupled receptors (GPCRs), which can exist
in dimeric and oligomeric complexes with other GPCRs,Corresponding author: Hill, S.J. (stephen.hill@nottingham.ac.uk).
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(AKAPs)] and adaptor molecules [such as b-arrestin and
receptor-activity-modifying proteins (RAMPs)] ([1–5] and
references therein). It is now evident that signalling from
cell-surface receptors is highly compartmentalised, with
receptors existing in close proximity to particular G-
proteins, their effectors and the enzymes responsible for
second-messenger metabolism [1,2]. Such organisation is
mediated by protein–protein and protein–lipid inter-
actions and is orchestrated by an association with the
cytoskeleton and the tendency of some proteins to partition
into membrane microdomains, such as lipid rafts and
caveolae [2,3]. This leads to the formation of signalling
microdomains, such as those described for receptors that
stimulate the formation of cAMP. Here, local second-mes-
senger concentrations are controlled by the proximity of
adenylyl cyclase, phosphodiesterases and cAMP-activated
protein kinase A [2,5]. A similar situation has been
described for receptors linked to increases in intracellular
calcium mediated by transient receptor potential (TRP)
channels [4].
The movement of GPCRs to and from such domains can
also be initiated by receptor stimulation. For instance, the
A1-adenosine receptor moves out of caveolae following
agonist stimulation, whereas, conversely, studies show
that muscarinic, b-adrenergic and bradykinin receptors
move into caveolae following activation ([1,3] and refer-
ences therein). Similarly, the movement of receptors to
clathrin pits can be initiated by agonist-mediated receptor
phosphorylation and the binding of adaptor proteins, such
as b-arrestin, adaptin and dynamin [6]. The formation of
such macromolecular complexes not only leads to the
movement of the receptor to clathrin-coated pits and its
subsequent intracellular trafficking but can also mediate
the activation of G-protein-independent signalling path-
ways, such as those leading to extracellular signal-related
kinase (ERK) activation [1,5].
Alternative coupling to different effector signalling
pathways can also have a major impact on the potency
and efficacy of particular ligands [6]. For example, the b-
adrenoceptor ligand propranolol is an inverse agonist.2007.09.008
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activate ERK1/2 through the same receptor in the same
cells [7,8]. It is, therefore, likely that the pharmacology of
GPCRs can differ markedly depending on their membrane
localisation and the signalling proteins present within that
locality. If GPCRs can exist in different signaling domains
within a single cell, then this will have important implica-
tions for the orchestration of drug action within a given cell
type and the potential for cross-talk with other signalling
pathways [9]. There is therefore an urgent need to develop
techniques that can study the molecular pharmacology of
GPCRs within specific membrane domains of single cells.
Fluorescence-based imaging technologies have been
used widely to assess the cellular distribution of GPCRs
and their associated signalling partners at a single-cell
level [10]. In particular, genetic tagging of either the
receptors themselves or associated proteins with green
fluorescent protein (GFP) has proved a powerful technique
for assessing the co-localisation of receptors and specific
raft markers. Confocal-based techniques, such as fluor-
escence recovery after photobleaching (FRAP) [11], have
provided useful information about the confinement of
GPCRs within membrane domains, their macroscopic dif-
fusion coefficients and how these are altered by receptor
stimulation (e.g. [12]). More sophisticated techniques, such
as fluorescence (Fo¨rster) or bioluminescence resonance-
energy transfer (FRET/BRET), have been used to probe
the proximity of receptor–receptor and receptor–effector
interactions directly (reviewed in [10]). However, none of
these techniques has both the temporal and spatial resol-
ution to determine the properties of ligand–receptor com-
plexes within membrane microdomains. In addition, they
lack the ability to quantify the concentrations of both free
and bound ligand, which are a prerequisite to the deter-
mination of potency and affinity.
Fluorescence correlation spectroscopy (FCS) is one tech-
nique with the potential to fill this gap [13–15]. As with the
earlier described techniques, FCS is noninvasive and can
be used on specific cell types within a mixed cell popu-
lation, making it ideal for use with small numbers of cells
(e.g. in samples obtained from biopsies). However, it also
has a resolution high enough to localize measurements
to areas of the cell membrane as small as some membrane
microdomains. Uniquely, it is quantitative and its wide
dynamic range allows the simultaneous detection of
both fast- and slow-moving species (e.g. both free and
receptor-bound ligand). Here, we discuss the application
of FCS-based techniques to measuring the subcellular
pharmacology of GPCRs.
FCS and its application to studying ligand–receptor
binding
The technique of FCS is based onmeasuring fluctuations in
fluorescence intensity as fluorescently labelled particles
diffuse through a small defined detection volume, which is
approximately 0.25 fl in size (roughly the same volume as a
mitochondrion) (Box 1). Statistical analysis of these fluctu-
ations using autocorrelation analysis gives information
about both the diffusion coefficient of the fluorescent
particles and their concentration. The concept of corre-
lation spectroscopy and the statistical principles involvedwww.sciencedirect.comwere originally described in the 1970s. However, it was not
until the advent of high-quality optics and photon-detec-
tion technology in the 1990s that the true power of the
technique was finally realized (see [15] for a history of FCS
development). This subsequently led to the application of
FCS to the study of ligand–receptor interactions, by virtue
of its ability to distinguish between species based on the
speed of their diffusion (Box 2). Such a difference is present
during ligand–receptor interactions because the diffusion
co-efficient of a fast-moving free fluorescent ligand just
above the cell surface decreases significantly when it binds
to a much slower moving membrane receptor.
FCS has been used to characterise the binding of ligands
to GPCRs, tyrosine-kinase receptors and ion channels [16–
21]. Ligand-binding affinities, receptor densities and off
rates for a number of different ligand–receptor combi-
nations have all been determined successfully. In each
case, even in heterogeneous cell populations from primary
sources, useful quantitative information about ligand–re-
ceptor interactions was obtained, supporting the applica-
bility of such methodology to studying pharmacology in
biopsy samples [18,19,22–25]. In the case of the insulin C-
peptide [18,22,23], kavain [25] and glucocorticoid receptors
[26,27], the FCS data provided the first direct evidence for
the existence of specific cell-surface GPCRs for these
ligands.
FCS using purified receptors
Ligand–receptor interactions were first quantified by FCS
using a fluorescently labelled version of a-bungarotoxin to
label the detergent-solubilised nicotinic acetylcholine re-
ceptor from Torpedo californica [28]. Although this study
was performed on purified protein, it established the prin-
ciple that FCS was capable of distinguishing free ligand
from bound in a single measurement, based on the differ-
ences in their diffusion coefficients. A number of other
similar studies have analysed binding to either membrane
vesicles (e.g. to endothelin and transferrin receptors) or
purified receptors [e.g. the 5-hydroxytryptamine-3 (5-HT3)
receptor] [29–31]. This approach, coupled with molecular
brightness analysis, is the basis for the use of fluorescent-
fluctuation techniques in high throughput screening [32].
In this application, the slower diffusion of individual mem-
brane vesicles, and the increase in molecular brightness as
ligand molecules bind to each vesicle, forms the basis for
identifying and separating the receptor-bound and free-
ligand components. However, the real power of FCS is in its
application to studying ligand–receptor interactions, in
conjunction with imaging technology, in single cells.
FCS measurements of receptor-fluorescent protein
fusions in living cells
Since cell-based FCS meaurements have become feasible,
one of the most widely used labelling strategies has been to
genetically tag the protein of interest with GFP or a related
fluorescent protein. Several studieshavedemonstrated that
FCS can measure diffusion of a tagged receptor in the cell
membrane directly and yield information about its mem-
brane environment. With respect to GPCRs, the membrane
diffusion of the complement C5a [33], bradykinin-BK2 [34]
andA1-adenosine receptors [35]haveall been characterised,
Box 1. Basic principles of FCS and autocorrelation analysis
FCS uses a small detection volume. This is created by focussing a
laser to a diffraction-limited spot using a microscope objective lens
with a high numerical aperture. Positioning of a pinhole in the
confocal image plane creates a Gaussian-shaped detection volume of
approximately 0.25–0.5 fl, depending on the excitation wavelength
[e.g. half axes of 0.15 (lateral) and 0.75 mm (axial) for 488 nm
excitation through a 1.2 NA objective lens, with the pinhole adjusted
to 1 Airy unit diameter]. As fluorescent molecules diffuse through this
volume, they are excited and the emitted photons are detected in a
time-correlated manner using a single photon-counting device, such
as an avalanche photodiode. Over time, this leads to fluctuations in
the detected fluorescent intensity. These fluctuations can be caused
by translational diffusion of the fluorescent species through the
volume but also by photophysical events within the fluorophore or
changes in its fluorescent properties, such as quantum yield or
interstate conversions (e.g. caused by conformational changes in the
labelled species) [13–15]. Autocorrelation analysis is a way of
analyzing the time-dependent changes in the amplitude of these
fluctuations about the mean fluorescent intensity. Autocorrelation
analysis compares the size of the fluctuation (dI) from the average
intensity (<I>) at time t with a subsequent fluctuation at a time t + t
later. This determines effectively whether the species responsible for
the fluorescence is still present in the volume. Using a range of values
for t, results in an autocorrelation function, G(t), which is usually
normalized to the square of the mean intensity (<I>). This function
yields information about the average dwell time (tD) and the average
number of molecules (N) of the fluorescent species within the
volume during the measurement. The dwell time (tD) is obtained
from the mid-point of the decay of the autocorrelation function, G(t).
Knowledge of the size of the detection volume (acquired using a
standard of known diffusion coefficient) can therefore yield the
diffusion coefficient of the species, which is related to properties,
such as molecular mass, hydrodynamic radius and viscosity of the
sample. In addition, because t!0, G(0)!1/N, where N is the average
number of particles within the detection volume during the measure-
ment. From this value, using knowledge of the shape and dimensions
of the detection volume, the absolute concentration of the detected
species can be calculated readily. ‘N’ and ‘tD’ are obtained from the
autocorrelation function by non-linear curve-fitting of the data to an
appropriate biophysical model, with the choice of model (e.g. 2D vs
3D, free vs anomalous diffusion) being crucial to the correct
quantification and interpretation of the data. With modern hardware
and detection technology, FCS can provide useful information over a
large range of fluctuation times (1 ms–500 ms) and has thus led to its
application in a number of fields, ranging from photo-physical
investigations and chemical reaction monitoring to cell-based studies
on protein diffusion. The inverse relationship between the autocorre-
lation function at time zero [G(0)] and the number of diffusing
particles (N) results in a greater sensitivity of the technique at lower
particle numbers, such that the concentration range that can be used
practically with FCS is between 0.1 and 400.0 nM, depending on
signal-to-noise ratio of the sample [corresponding to an average
particle number (N) of 0.01–40.0]. This signal-to-noise ratio, particu-
larly in cells, can be severely affected by non-correlated background
signal, such as shot noise or autofluorescence, although this can be
accounted for in the biophysical model used. Further artefacts can be
introduced by not allowing for the photophysics and photobleaching
of the fluorescent label (Figure I).
Figure I. Basic principles of FCS. (a) Schemative representation of the confocal detection volume. (b) Variations in the detected fluorescence intensity with time. (c)
Autocorrelation analysis of fluorescence fluctuations (see text for details).
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factor (EGF) receptor [36]. For the A1-receptor, a single
diffusing species was identified, which was identical to that
found for the diffusion of the antagonist-occupied receptorwww.sciencedirect.com(see later) [35]. The heterogeneous diffusion of the other
receptors was described variously in two to three different
populations, suggesting the presence of the receptor in a
number of different membrane environments [33,34].
Box 2. FCS enables the distinction between free and bound ligand in small areas of cell membrane
In complex mixtures, in which two fluorescent species with differing
diffusion coefficients are present, their autocorrelation functions
(Box 1) are simply additive, resulting in a biphasic decay curve for
G(t). This can yield diffusion coefficients for both species and also
enables the calculation of their individual concentrations from their
relative contributions to the amplitude of the function. It is this
property of the analysis that proves useful for investigating ligand–
receptor interactions. A free ligand molecule in the vicinity of the
cell membrane will show fast 3D Brownian diffusion, at a rate
corresponding to its molecular mass. If that ligand binds subse-
quently to a slow-moving membrane-localised receptor, its diffu-
sion coefficient will be reduced substantially. Therefore, placing the
FCS detection volume on the cell membrane will yield an
autocorrelation function composed of a fast-moving component
(representing the free ligand diffusion) and one or more slow-
moving components (representing the membrane-bound ligand)
[83]. This is illustrated (Figure I) with fluctuation data obtained on
the upper membrane of CHO cells expressing the human A1-
adenosine receptor labelled with a fluorescent antagonist that binds
to this receptor (XAC-BY630) [35]. Fluorescence fluctuations
obtained 5 mm above the cell are produced by fast-moving free
ligand alone. Autocorrelation analysis of these fluctuations results
in a monophasic decay curve, with a diffusion time showing a
single fast-moving component. The average dwell time (tD) of a
particular species is determined from the mid-point of the decay of
the autocorrelation function [G(t)]. For example, for the diffusional
characteristics of the free ligand in the figure, tD1 is 65 ms.
Fluctuations recorded when the volume is placed in a position
incorporating both extracellular solution and cell membrane are
quantitatively and qualitatively different in their amplitude and
temporal nature. This is owing to the presence of slower moving
receptor–ligand complexes (and possibly non-specifically bound
ligand). Autocorrelation analysis now reveals a more complex curve
showing additional slow moving components representing bound
ligand (tD2 and tD3). Fitting of the autocorrelation function to an
appropriate biophysical diffusion model through non-linear curve-
fitting enables the proportion of each component present to be
calculated. This information can then be used to calculate the actual
concentrations of free ligand and ligand-occupied receptor within
the measurement volume. The quantitative biophysical model used
for the curve fitting needs to be appropriate for the system. In this
case, the model used assumed free 3D diffusion of the free ligand
and free 2D diffusion of the bound components. The fitted equation
also incorporated terms for particle number, photo-physical fluctua-
tions from the fluorophore and the geometric shape of the volume.
Such quantification also relies on a number of other conditions, for
instance, low background noise and autofluorescence. In particular,
the free and bound ligand should have identical molecular bright-
ness (quantum yield) or the determination of N is skewed heavily
toward the brighter species. Under these conditions, FCS measure-
ments are therefore capable of yielding the true free concentration
of ligand in the immediate vicinity of the receptor, in addition to the
diffusion coefficients and concentrations of any ligand-occupied
receptors.
Figure I. (a) Fluorescence fluctuations obtained above (blue trace) and on the membrane (red trace) of CHO cells expressing the human A1-adenosine receptor following
incubation with a fluorescent receptor antagonist, XAC-BY630. (b) Corresponding autocorrelation analysis of the fluorescence fluctuations obtained. (c) Confocal
images of CHO cells expressing a fluorescently (Topaz)-tagged variant of the A1-adenosine receptor, incubated with XAC-BY630 in the presence and absence of the non-
fluorescent receptor ligand DPCPX, showing a high degree of specific binding of the fluorescent receptor antagonist.
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In the majority of examples in which fluorescent ligands
have been used to monitor receptor properties, agonist
peptide ligands have been used to provide information
on the diffusional characteristics of agonist-occupied recep-
tors. Generally, this is because endogenous peptides (e.g.
insulin and galanin) can be labelled readily. In addition,
the extracellular-facing binding site of the receptor is
sufficiently accessible to the ligand that there is less chance
of the fluorophore interfering with its pharmacological
action. However, in the case of GPCRs that have low
molecular weight ligands, the design of fluorescent ligands
is more complex because the binding site is often located
within the transmembrane regions of the receptor [37]. In
many cases, the addition of a fluorophore as large as the
ligand itself creates a pharmacological entity that differs
significantly in both potency and efficacy to the parent
compound [35,37,38]. Choice of the correct fluorophore
(both from a photophysical and pharmacological perspect-
ive) and an appropriate linker can be crucial to maintain-
ing functional activity [24,30,38].
All FCS ligand-binding studies undertaken to date
indicate that agonist-occupied receptors can exist in at
least two forms within the cell membrane (indicated gener-
ally by tD2 and tD3, with tD1 representing free ligand; Box 2,
Table 1). These forms might represent receptor present in
different membrane domains or associated with different
cytoskeletal or scaffolding proteins. They might also be
indicative of different functional forms of the ligand–re-
ceptor complex. The actual diffusion coefficients obtained
for these species vary among studies, although their dwell
times within the confocal volume fall generally within theTable 1. Summary of receptor–ligand-binding studies using FCS
Receptor class Receptor Ligand Activity
7TM Adenosine-A1 XAC-BY630 Antagonist
ABA-BY630 Agonist
ABEA-BY630 Agonist
A1-AR-Topaz Receptor
Adenosine-A3 ABEA-BY630 Agonist
Bradykinin-BK2 BK2R-YFP Receptor
Complement-C5a C5aR-YFP
b2-adrenoceptor AF532-arterenol Agonist
Galanin Rh–galanin Agonist
Tyrosine
kinase
Insulin Rh–insulin Agonist
EGF Rh–EGF Agonist
EGFR-mRFP Receptor
Ion channel GABAA AF532-muscimol Allosteric
modulator
AF532-Ro07-1986/602 Allosteric
modulator
5-HT3 Cy5-GR119556 Antagonist
Misc. Glucocorticoid
receptor
FITC–dexamethasone Agonist
C-peptide Rh–C-peptide Unknown
IgE AF488-IgE Activator
The table summarises the ligand–receptor species detected in FCS experiments using
aOther experiments in this study using scanning FCS indicate tD2 = 72%, tD3 = 12%, wit
bDiffusion times are estimates calculated from published diffusion coefficients (D), using t
(488 nm).
cAs for b, except r = 0.17 mm (514 nm).
dAs for b, except the equation used was tD = r
2/8D, as multiphoton excitation was used
7TM, seven transmembrane spanning receptor; BK, bradykinin; FITC, fluorescein isothi
www.sciencedirect.com1–10 ms range for the faster species (tD2) and more than
50 ms (tD3) for the slower species (summarized in Table 1).
It should be noted, however, that each of these two ‘bound’
components might actually be a composite of multiple
species with differing diffusion coefficients. However, the
relative amounts of these components differ significantly
among receptor types. For instance, the agonist-occupied
galanin receptor exists predominantly as tD2 (88%) [19],
whereas tetramethyl rhodamine (TMR)–EGF binding con-
sisted largely of tD3 (75%) [17]. Binding of two different
fluorescent A1-receptor agonists (ABA- and ABEA-X-
BY630) to the A1-receptor consisted of approximately equal
amounts of each component [38,39]. Interestingly, a much
higher percentage of the slower-diffusing tD3 component
was observed using the same ligand at the closely related
A3-adenosine receptor expressed in the same cell type [40].
There is some circumstantial evidence to suggest that
these diffusion components might relate to different func-
tional forms of the receptor. For example, when FCS was
used to measure the binding of labelled insulin [16], EGF
[17] or kavain [25] to their respective receptors, different
affinity states of the receptor appeared to be associated
with the different diffusional components. Similarly, when
a fluorescent dexamethasone derivative was used to detect
cell-surface glucocorticoid receptors in a pituitary cell line,
increasing the concentration of the ligand in a range
approaching its measured affinity resulted in a shift from
predominantly tD2 to predominantly tD3 [26,27]. In
addition, the non-raft marker, DiO, showed a diffusion
time comparable with that for tD2, indicating that the
cell-surface glucocorticoid receptor might move from
non-raft domains to a more rigid raft-like domain onCells Component 1
(tD2; ms, %)
Component 2
(tD3; ms, %)
Refs
CHO (hamster ovary) 17 (85%) 321(15%) [35]
CHO 8 (48%) 233 (52%) [39]
CHO 9 (40%) 267 (60%) [38]
CHO 15 (100%) [35]
CHO 6 (25%) 135 (75%) [40]
HEK (human kidney) 16 (n.d.)a,b 140 (n.d.)a,b [34]
HEK 2 (100%)c [33]
Rat neurones 1.8 (78%) 160 (22%) [20]
A549 cells (alveolar) 3 (66%) 45 (33%)
C6 cells (glioma) 0.7 (65%) 9.4 (35%)
Rinm5F (rat insulinoma) 22 (88%) 700 (12%) [19]
Human renal tubular 0.8 (51%) 20 (49%) [16]
Human fibroblasts 3 (24%) 100 (76%) [17]
CHO 54 (100%) [36]
Rat neurons 4 (79%) 72 (21%) [22]
7 (n.d.) 360 (n.d.) [25]
HEK293 1–10 (n.d.) >20 (n.d.) [43]
AtT20 (mouse pituitary) 4 (25%) 250 (65%) [27,28]
Human renal tubular 1 (17%) 80 (83%) [18]
RBL (mast cells) 80 (100%)d [56]
a variety of receptors and ligand types (n.d. = not determined).
h 16% consisting of a slower diffusing third component.
he equation tD = r
2/4D, where r = 0.15 mm, estimated from the excitation wavelength
, with r = 0.25 mm.
ocyanate; GABA, g-amino butyric acid.
Figure 1. Using a range of labelling techniques enables subpopulations of receptor
complexes to be studied. This diagram, based on the extended ternary-complex
model, illustrates the receptor species likely to be present in a cell expressing a
receptor (R) and a GTP-binding protein (G) in the presence of a ligand (A). The
receptor can be present in either inactive (R) or active (R*) conformations, each of
which can be found bound to G-protein (RG and R*G), ligand (AR and AR*) or both
(ARG and AR*G). The coloured indicators show the species that are most likely to
be detected when different labelling strategies are used for FCS experiments (see
text). Green highlights directly tagged GPCRs (e.g. with GFP), which will represent
the total ligand-unoccupied receptor population. Blue highlights the low
concentrations of ligand used in FCS, at which an inverse agonist is likely to
label predominantly the inactive forms of the receptor (R and RG). Red highlights
that, similarly, at such low concentrations, an agonist ligand will detect mainly
activated receptor (R* and R*G). However, because the intracellular concentration
of GTP is high, any R*G formed will revert rapidly to R* and this will be the
predominant form detected.
642 Review TRENDS in Pharmacological Sciences Vol.28 No.12agonist activation. Some evidence also exists for the
conversion of one diffusional component into another
following more prolonged agonist stimulation (e.g. the
b2-adrenoceptor), which might be related to receptor clus-
tering prior to internalisation [20,41].
Antagonist-receptor binding
Two studies have used antagonist ligands to measure cell-
surface receptor diffusion. For the 5-HT3 receptor,
antagonist-occupied receptors were also detected in fast-
and slow-moving forms [42]. The diffusion coefficients
obtained appeared to correlate directly with receptor
location and the slow-moving component (tD3) was
observed predominantly when the FCS detection volume
was positioned over receptors that appeared clustered on
the cell surface. The antagonist-occupied A1-receptor was
described predominantly by a diffusion component (tD2) of
15 ms. This was the same as that obtained for the tagged
receptor itself [35]. Our studies using FCS to study the
diffusion of the ligand-occupied A1-receptors are the only
ones to have used both an agonist and antagonist ligand in
the same cell line [35,38,39]. They appear to reveal sig-
nificant differences between the diffusional properties of
the agonist- and antagonist-occupied receptor populations,
with the diffusion coefficients for both tD2 and tD3 of the
agonist-occupied receptor being significantly faster than
those obtained with the antagonist. In addition, in the case
of the agonist, both of these components appeared to be
equally sensitive to the displacement by competitor,
whereas, for the antagonist, tD3 appeared to be largely
resistant to competitor. However, the most probable expla-
nation for these differences is that agonist and antagonist
ligands, under the conditions used in these FCS exper-
iments, are labelling different functional forms of the re-
ceptor (see later and Figure 1).
Progressing toward domain-specific pharmacology
For FCS to achieve the goal of assigning populations of
occupied receptors with different diffusion coefficients to
specific functional domains, signalling complexes or lipid
rafts, the basic ligand-binding techniques described here
need to be extended. Fortunately, advances in FCS tech-
nology, data analysis and labelling technologies in recent
years suggest that this is certainly possible.
Localising measurements to specific domains
Precise positioning of the FCS measurement volume over
defined receptor clusters is possible using confocal ima-
ging, as has already been demonstrated for ligand binding
measurements on the 5-HT3 receptor [42]. It is, therefore,
possible to use domain markers (separated spectrally from
the ligand or receptor tag) to localise measurements to the
domains of interest and to characterise diffusion of the
receptors that are co-localised. Such markers have been
used previously in conjunction with FCS in artificial sys-
tems (e.g. [43]). More recently, they have been used to label
membrane domains in living cells and, subsequently, to
measure domain diffusion [43–45]. For instance, diffusion
of lipid-based raft and non-raft markers differed signifi-
cantly in both RBL and COS-7 cells [43–45]. GFP-tagged
transmembrance proteins or receptors, known to localise towww.sciencedirect.comspecific membrane domains, have also been used as
domain markers. For instance, a transferrin receptor–
GFP fusion protein (non-raft) showed significantly faster
diffusion than GFP–Thy1 (known to localise to rafts) [44].
Fluorescently labelled cholera toxin B-subunit (CTx-B) has
also been used to label rafts in live cells [43,46]. Interest-
ingly, the diffusion coefficients obtained in these exper-
iments are of the same order of magnitude as those found
for ligand-occupied receptors in the FCS studies. These
studies also illustrate how the slow movements of strongly
anchored domains are not detected easily using fluctuation
techniques [43]. For example, when themembranes of RBL
cells were labelled with fluorescent CTx-B, a strong fluor-
escence signal was detected, but diffusion of the label could
only be seen when the cytoskeleton was disrupted [43,46].
This inability to detect effectively immobile particles,
such as those anchored strongly to the cytoskeleton, is a
limitation of standard FCS analysis. It stems from the
essential requirement of autocorrelation analysis to have
fluctuations in fluorescence over time, which are not
present if there is limited diffusion within the detection
volume. This can also limit the use of FCS in situations in
which there is a large background population of fluor-
escent but immobile receptors. Detection of fluctuations
on such a high background count can be difficult. Tech-
niques such as image correlation spectroscopy (ICS) and
raster ICS both use statistical analysis of images to obtain
information about particle diffusion. The analysis used in
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background and can, in some cases, actually provide an
estimation of an immobile fraction [47,48]. Information on
immobile fractions can also be provided on a macroscopic
scale by techniques, such as FRAP. The recent develop-
ment of scanning FCS (sFCS) might also help in the
detection of very slow moving species [49–51]. Scanning
FCS uses a moving illumination volume, scanned over the
sample at a fixed velocity, enabling the detection of
fluctuations from multiple points on its orbit. Autocorre-
lation analysis of sFCS data thus enables us to see if the
signal is still present each time the beam returns to the
same point. Because the orbital velocity of the beam is
relatively slow (ms to s), this enables the detection of very
slow moving species much more efficiently than standard
single-point FCS. As an example, the application of sFCS
to studies on the GFP-tagged bradykinin BK2 receptor,
enabled the more accurate determination of a very slow
moving receptor population that was not detected using
single-point FCS measurements [34].
Measuring specific receptor species in isolation
Comparisons of domain diffusion with those of ligand-
occupied receptors or receptor–GFP fusion proteins pro-
vide some evidence for differences in the localization of, for
instance, agonist- and antagonist-occupied receptors. How-
ever, simply showing that a receptor species and a domain
have the same diffusion properties does not definitively
place the species within that domain. The assignation of a
species to a particular diffusion time is complex because
differing domains might possess similar diffusion times
and it is unlikely that a specific receptor species will be
present in a given domain exclusively. Is it possible, there-
fore, to use FCS-based techniques to monitor specifically
the diffusion of particular functional forms of the receptor
or specific receptor–protein complexes?
As illustrated in Figure 1, the particular method used
for labelling the receptor in the cell membrane already
gives some degree of specificity in terms of the species of
receptor that is detected. For instance, in terms of the cubic
ternary complex model of GPCR activation [52], using a
GFP-tagged version of the receptor itself will provide
information about the properties of the total unoccupied
receptor population (R, R*, RG and R*G; see Figure 1 for
definitions). By definition, FCS uses low concentrations of
fluorescent ligands and therefore operates at low receptor
occupancies. In the case of an inverse agonist ligand, this
will lead primarily to the detection of AR and ARG. Like-
wise, in intact cells in which the GTP concentration is high,
low concentrations of agonist will detect AR* predomi-
nantly. This could explain some of the discrepancies seen
in Table 1 but could also indicate differences in membrane
properties of these receptor species. Allocation of such
species to the tD2 and tD3 values obtained becomes more
feasible in these situations. In particular, the use of a range
of receptor ligands, both agonist and inverse agonist, with
varying efficacies and potencies should enable the delinea-
tion of tD2 and tD3 and their assignment to different
functional forms of the receptor.
Somenewer andmore advanced versions of fluorescence-
fluctuation techniques might also help in identifyingwww.sciencedirect.comthe diffusion properties of specific receptor–ligand and
receptor–protein complexes. The first of these, two-colour
cross-correlation FCS (FCCS), uses two overlapping detec-
tion volumes, usually provided by two co-focussed lasers of
differing wavelengths [14,53]. Emission from two spectrally
distinct fluorophores is separated into two detection chan-
nels and the fluorescence fluctuations in each can be auto-
correlated. In addition to this, however, fluctuations can be
correlated between the two channels (cross-correlated). A
cross-correlation signal is therefore onlyobtainedwhenboth
fluorescent species are present in the volume at the same
time and gives an indication of the two species interacting.
This enables both the diffusion coefficient and concentration
of the dual-labelled species to be determined. Unlike FRET,
for instance, FCCS does not rely on the proximity of the
interacting components to obtain a signal but simply
their co-diffusion. FCCShas been used in a number of single
cell-based studies, including tracking the dissociation of
cholera-toxin subunits [46], monitoring the interaction of
calmodulin andCa2+/Calmodulin-dependent protein kinase
II (CaMKII) [54,55], detecting the interaction of the tyrosine
kinaseLynwith theFce receptor [56], investigating immedi-
ate early gene dimerisation [57] and following caspase-3
activity [58,59].When applied to the study of GPCRs, FCCS
will be useful in the specific detection of ligand-occupied
receptors and in detecting receptors interactingwith signal-
ling partners (e.g. G-proteins), scaffolding proteins (e.g.
clathrin, caveolin) or other receptors (e.g. dimerisation).
For instance, somatostatinanalogues labelledwithdifferent
fluorophores were used to obtain a cross-correlation signal
at the cell membrane, which indicated the presence of re-
ceptor dimers [60]. FCCS is difficult to perform technically
but recent improvements in FCCS methodology will
improve the applicability of this technique to cell-based
applications [61–63]. For instance, in single-wavelength
excitation FCCS, a single excitation volume is used to excite
both fluorescent species, ensuring 100% overlap in the
excitation volumes. Single-wavelength FCCShas been used
recently to investigate the proportion of dimer formation of
the EGF receptor in living cells [64].
A further method that has been developed recently,
bimolecular fluorescence complementation (BiFC), could
also prove a valuable tool in isolating the diffusion proper-
ties of particular receptor complexes (reviewed in [65]).
BiFC uses two non-fluorescent fragments of a fluorescent
protein, such as yellow fluorescent protein (YFP), which
regain their fluorescent properties when reconstituted.
Fusion proteins made containing the non-fluorescent N-
and C-fragments are constructed, such that fluorescence is
only seen when the two proteins are in close enough
proximity that reconstitution by complementation of
full-length fluorescent protein is obtained. This enables
the detection of specific fluorescent species with a high
signal-to-noise ratio and has already been used to monitor
the diffusion of GPCR oligomers [66] and to localise specific
combinations of G-protein b and g subunits [67,68].
FCS andFCCS are based on the temporal analysis of the
fluorescence fluctuations, thus providing information
about the dwell times of species within the detection
volume. Diffusional analysis is limited to some degree,
however, because at least a 1.6-fold change in diffusion
644 Review TRENDS in Pharmacological Sciences Vol.28 No.12time (corresponding to a 6-fold change in mass) is required
to reliably differentiate between two species [69]. This
would not distinguish, for instance, between monomeric
and dimeric species of GPCRs based on mass difference
alone. Analysis of the fluctuations with respect to the
brightness of the fluorescent species, by either photon-
counting histogram analysis (PCH) [70] or fluorescent-
intensity distribution analysis (FIDA) [71], however,
affords information about particle number and molecular
brightness. This can distinguish heterogenous species that
differ by only twofold in their molecular brightness (e.g.
monomer vs dimer) [72]. The existence of a range of oli-
gomer sizes for the EGF receptor and the effect of choles-
terol on this distribution has been demonstrated recently
using FIDA [73]. In other examples, PCHanalysis has been
used to show the formation of higher-order oligomers of the
Na+/H+ co-transporter [74], whereas similar analysis
detected dimeric species of membrane-bound adenylate
kinase [75]. In a similar manner, PCH has been used to
monitor aggregation of the retinoid receptor and to deter-
mine the stoichiometry of its binding [76,77]. More
recently, the use of two-colour PCH in cells raises the
possibility that multiple species could be monitored sim-
ultaneously using this technique [78].
Conclusions
FCS has already proved a powerful technique for quantify-
ing the diffusion of receptors and ligand–receptor com-
plexes in small areas of living cell membranes. It gives
us new information about the distribution and organis-
ation of membrane receptors and enables such analysis to
be performed in heterogeneous cell populations. A number
of recent advances in FCS technologies, such as total
internal reflection-FCS [79–81] and the use of nanostruc-
tures [82], could further increase the axial resolution of
these measurements. Coupled with the newer labelling
technologies described and the availability of fluorescent
ligands with a wider range of affinities, the delineation of
the properties of specific receptor–ligand and receptor–
protein complexes at a subcellular level is a real possibility.References
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